Company

Company

Relevant Interviews, Webinar and Trial Updates posted by CRISPR Medicine News.

Always stay updated with the free CMN Newsletter.

ArtisanBio

Main focus: CRISPR-edited cellular therapies

Company stage: Pre-clinical

Diseases (gene editing): Cancer

Genome editing tool: CRISPR

Funding stage: Private

Location: Denver, Colorado, USA

Website: https://artisancells.com/

Pipeline: https://artisancells.com/portfolio/

Gene-editing partnerships: Multiple undisclosed

ArtisanBio develops CRISPR-engineered cellular therapies to treat various undisclosed types of cancers. The company combines CRISPR gene editing with high-throughput workflows and data analysis to enable multiplex engineering of cells. The company yet has to disclose the details of its lead pre-clinical programmes.

Your Latest CMN News

CMN Weekly (19 April 2024) - Your Weekly CRISPR...

Some of the best links we picked up around the internet

A Secondary Checkpoint Refines CRISPR Precision

New findings highlight a secondary conformational checkpoint in CRISPR-Cas9 that significantly enhances its accuracy in gene editing.

Cancer's Weak Point Is Its Metabolism, CRISPR...

American researchers have developed a novel CRISPR-based platform to identify and characterise essential nutrient transporters that support cancer...

Next-Generation CRISPR Screening Libraries Without...

Sponsored content

Founded in 2018, Vivlion is a spin-out of Goethe University Frankfurt. Its mission is to provide innovative gene-editing reagents and screening...

CMN Weekly (12 April 2024) - Your Weekly CRISPR...

Some of the best links we picked up around the internet

Scientists use CRISPR to develop new detection...

Scientists in China describe a sensitive and selective CRISPR-Cas12-based assay for the detection of a protein that is implicated in obesity and...

Company: ArtisanBio

Search CRISPR Medicine